Cardenolide-rich fraction of Pergularia tomentosa as a novel Antiangiogenic agent mainly targeting endothelial cell migration
Author(s) -
Mahya Hosseini,
Mahdi Ayyari,
Anna Meyfour,
Sonia Piacente,
Antonietta Cerulli,
Alexander D. Crawford,
Sara Pahlavan
Publication year - 2020
Publication title -
daru journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.645
H-Index - 42
eISSN - 2008-2231
pISSN - 1560-8115
DOI - 10.1007/s40199-020-00356-7
Subject(s) - chorioallantoic membrane , umbilical vein , biology , angiogenesis , human umbilical vein endothelial cell , in vivo , endothelial stem cell , microbiology and biotechnology , pharmacology , in vitro , biochemistry , cancer research
Angiogenesis related abnormalities underlie several life-threatening disorders. Despite approved therapies, scientists have yet to develop highly efficient, low cost approaches with minimal side effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom